Canada· CA-DIN-02472449
BERRY LIP BALM
A d02ba30 product containing octisalate + octinoxate, registered in Canada by BLISTEX CORPORATION.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- OCTISALATE + OCTINOXATE
- Manufacturer
- BLISTEX CORPORATION
- Country
- Canada (CA)
- ATC code
- D02BA30
- ATC class
- D02BA30
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
D02ba30 in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c358febf-fd2b-43d2-9fa9-57c7ffb1eaf4 GET /v1/drugs/c358febf-fd2b-43d2-9fa9-57c7ffb1eaf4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02472449",
"form": "STICK",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "D02BA30",
"schedule": [
"OTC"
],
"drug_code": "96176",
"strengths": [
"4.4 %",
"6.6 %"
],
"ahfs_class": null,
"substances": [
"OCTISALATE",
"OCTINOXATE"
],
"product_categorization": "CAT IV - SUNBURN PROTECTANTS"
}See everything about d02ba30.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.